bicalutamide
Showing 26 - 50 of 108
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)
Recruiting
- Prostatic Neoplasms
- Leuprorelin
- +6 more
-
Cheongju, Korea, Republic of
- +9 more
Jul 28, 2021
Prostate Cancer, Hormone-Dependent Prostate Cancer Trial in Worldwide (SHR3680, Bicalutamide)
Active, not recruiting
- Prostate Cancer
- Hormone-Dependent Prostate Cancer
- SHR3680
- Bicalutamide
-
Burgas, Bulgaria
- +66 more
Feb 28, 2021
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
- TAK-700
- Bicalutamide
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Prostate Cancer Trial in Shanghai (Bicalutamide, goserelin acetate, flutamide)
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 5, 2020
Prostatic Tumors Trial in Japan (Androgen-deprivation Therapy (ADT), Bicalutamide, Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Androgen-deprivation Therapy (ADT)
- +6 more
-
Akita, Japan
- +76 more
Jan 19, 2023
Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial (Bicalutamide, Laboratory Biomarker Analysis,
Withdrawn
- Stage I Prostate Adenocarcinoma
- Stage II Prostate Adenocarcinoma
- Bicalutamide
- +3 more
- (no location specified)
Jan 17, 2019
Prostate Cancer Trial in Canada (drug, procedure, radiation)
Terminated
- Prostate Cancer
- bicalutamide
- +8 more
-
Calgary, Canada
- +12 more
Mar 31, 2020
Prostate Cancer Trial in Canada (bicalutamide, buserelin, cyproterone acetate)
Completed
- Prostate Cancer
- bicalutamide
- +6 more
-
Calgary, Alberta, Canada
- +28 more
Jun 21, 2021
Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Canada, Puerto
Active, not recruiting
- Stage I Prostate Adenocarcinoma
- +2 more
- Bicalutamide
- +7 more
-
Mobile, Alabama
- +313 more
Sep 7, 2022
Prostate Cancer Trial in Canada (drug, procedure, radiation)
Completed
- Prostate Cancer
- bicalutamide
- +7 more
-
Edmonton, Alberta, Canada
- +14 more
Apr 1, 2020
Prostate Cancer Trial in Canada, United States (Radiation Therapy, Enzalutamide, Bicalutamide)
Recruiting
- Prostate Cancer
- Radiation Therapy
- +3 more
-
Gilbert, Arizona
- +107 more
Mar 17, 2022
Prostate Cancer Trial in Worldwide (bicalutamide, docetaxel, doxorubicin HCl)
Completed
- Prostate Cancer
- bicalutamide
- +8 more
-
Phoenix, Arizona
- +77 more
Oct 21, 2020
Prostate Cancer Trial in Canada, United States (bicalutamide, estramustine phosphate sodium, etoposide)
Completed
- Prostate Cancer
- bicalutamide
- +7 more
-
Birmingham, Alabama
- +53 more
Oct 19, 2020
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Mexico, United
Recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone
- +14 more
-
Gilbert, Arizona
- +301 more
Nov 8, 2021
Prostate Cancer Trial in Houston (Bicalutamide, Doxorubicin HCl, Estramustine Phosphate Sodium)
Completed
- Prostate Cancer
- Bicalutamide
- +8 more
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Oct 30, 2018
Breast Cancer Trial in Shanghai (Bicalutamide)
Terminated
- Breast Cancer
- Bicalutamide
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 21, 2018
Prostate Cancer Trial in Sacramento (Bicalutamide, Everolimus)
Completed
- Prostate Cancer
- Bicalutamide
- Everolimus
-
Sacramento, CaliforniaUniversity of California Davis Cancer Center
Jan 5, 2018
Prostate Cancer, Prostatic Tumors Trial in United States (Panobinostat, Bicalutamide)
Completed
- Prostate Cancer
- Prostatic Neoplasms
- Panobinostat
- Bicalutamide
-
New Brunswick, New Jersey
- +3 more
Jan 10, 2018
Prostate Cancer Trial in United States (Enzalutamide, Bicalutamide)
Breast Cancer Trial in Guangzhou (Bicalutamide, Aromatase Inhibitor)
Unknown status
- Breast Cancer
- Bicalutamide
- Aromatase Inhibitor
-
Guangzhou, Guangdong, ChinaState Key Laboratory of Oncology in South China,Sun Yat-sen Univ
Dec 21, 2017